查看更多
North America Equity ResearchJanuary 2021Animal Health Diagnostics – Ideally Positioned to Benefit from Pet Care TailwindsInitiating Coverage of IDXX and HSKA with OW RatingsPharmaceuticals Chris Schott, CFA AC (1-212) 622-5676mailto:christopher.t.schott@christopher.t.schott@J.P. Morgan Securities LLCChristopher Neyor(1-212) 622-0334mailto:christopher.z.neyor@cmailto:hristopher.z.neyor@hristopher.z.neyor@J.P. Morgan Securities LLCEkaterina Knyazkova(1-212) 622-9576mailto:ekaterina.v.knyazkova@ekaterina.v.knyazkova@J.P. Morgan Securities LLCXiling Chen(1-212) 622-0364mailto:xiling.chen@xiling.chen@J.P. Morgan Securities LLCSee the end pages of this presentation for analyst certification and important disclosures, including non-US analyst disclosures.J.P. Morgan does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.Diagnostics Represent One of the Most Attractive Segments of the Animal Health MarketDiagnostics represent one of the most attractive segments of the Animal Health market, in our view, with an estimated 8% annual CAGRThe utilization of diagnostics remains low, but we are seeing vets increasingly integrate these products into their practicesOnly 22% of sick visits and 9% of wellness visits include a bloodwork diagnostic despite best-in-class utilization of~40%Vets are highly incentivized to adopt diagnostics, particularly due to structural changes in the Rx market, which traditionally accounted for a substantial portion of practice profitabilityC and others are changing the longer-term economics of vet practices, a trend that favors diagnosticsPet owners are showing an increased willingness to pay more to support their pet’s healthCOVID-19 has accelerated this trendOverall share in the Animal Heal
相关知识
【宠物研报】J.P.摩根
研报笔记
依依股份:宠物护理用品龙头竞争优势凸显,需求有望进一步修复(国海证券研报)
读研报心得:康华生物狂犬疫苗领航,宠物疫苗与诺如疫苗驱动成长
美国最古老的宠物公墓里安葬着无数人的思念
宠物行业期刊(宠物行业研报)
劳动报
宠物报,宠物行业新媒体!
【5万报宠物旅行团,...
【#5万报宠物旅行团...
网址: 【宠物研报】J.P.摩根 https://m.mcbbbk.com/newsview73771.html
上一篇: 每日风险投资速递2024.08. |
下一篇: 宠物诊断试剂,你把握住这个行业的 |